Historical record - last NADAC effective date: 8/23/2023
Product Information
PIOGLITAZONE HCL 30 MG TABLET is a generic product labeled by Solco Healthcare US LLC, priced at $0.1173 per EA under NDC 43547042709. Its NADAC has been published 235 times since Feb 27, 2019.
FDA first approved this application on Apr 17, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Pioglitazone market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
30 mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547042709
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/23/2023
Active Ingredients
PIOGLITAZONEApproval Type
Generic (ANDA)
FDA Application
ANDA207806FDA Approved
4/17/2018
TE Code
AB
On Market Since
5/20/2018
Pharmacological Classes
Price Statistics
The NADAC for PIOGLITAZONE HCL 30 MG TABLET has been published 235 times since Feb 27, 2019, and over the history we have for it it has risen 10.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1173 per EA |
|---|---|
| All-time high | $0.1632 (Oct 14, 2020) |
| All-time low | $0.1041 (Apr 17, 2019) |
| Median price | $0.1280 |
| Average price | $0.1323 |
| Largest weekly change | +18.6% (Jun 17, 2020) |
| Weeks tracked | 235 |
| Tracking since | Feb 27, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+3.4%
5Y
-23.8%
All
+10.6%
Last surveyed Aug 23, 2023 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 23% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PIOGLITAZONE HCL 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PIOGLITAZONE HCL 30 MG TABLET, manufactured by Solco Healthcare US LLC, is $0.1173 per EA (NDC 43547042709), effective Aug 23, 2023.
How has the price of PIOGLITAZONE HCL 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for PIOGLITAZONE HCL 30 MG TABLET has risen 10.6%. It has been tracked across 235 weekly CMS publications since Feb 27, 2019.
What are the highest and lowest recorded NADAC prices for PIOGLITAZONE HCL 30 MG TABLET?
Since Feb 27, 2019, the NADAC for PIOGLITAZONE HCL 30 MG TABLET has ranged from a low of $0.1041 (Apr 17, 2019) to a high of $0.1632 (Oct 14, 2020), with a median of $0.1280 per EA.
Are there cheaper alternatives to PIOGLITAZONE HCL 30 MG TABLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PIOGLITAZONE HCL 30 MG TABLET, is $0.0903 per EA — about 23% below PIOGLITAZONE HCL 30 MG TABLET.
Who manufactures PIOGLITAZONE HCL 30 MG TABLET?
PIOGLITAZONE HCL 30 MG TABLET (NDC 43547042709) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.